Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Randomised Controlled Trial of Frontoparietal and Temporoparietal Electroconvulsive Therapy (ECT) for Severe Depression: The RAFT ECT Study

NCT05402657 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT05402657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05402657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Randomised Controlled Trial of Frontoparietal and Temporoparietal Electroconvulsive Therapy (ECT) for Severe Depression: The RAFT ECT Study
Lead sponsor
The George Institute
Phase
Not applicable
Overall status
Completed
Start date
March 22, 2023
Completion date
February 13, 2026
Enrollment
156 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive episode